What OWCP has is a product that is about ready for commercialization. Revenues to be realized this year. CNBX looks to have a great product that will take years to get to market and millions of dollars doing research and development if they want FDA approval. We have a better delivery system using sublingual tablets because it allows for exact and measurable amounts of medicine to be delivered via the buccal cavity... the contents get absorbed in the mouth bypassing the digestive process. That is a huge plus medicinally and it also allows for our medicines to be non psychoactive. It appears as though CNBX product, while probably effective, is psychoactive thus the need for low doses in stages.
(1)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links